Literature DB >> 19246171

Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection.

T R O'Rourke1, F K S Welsh, P P Tekkis, N Lyle, A Mustajab, T G John, D Peppercorn, M Rees.   

Abstract

BACKGROUND/AIMS: To evaluate the diagnostic precision of chemical-shift imaging MRI and ferucarbotran-enhanced MRI for hepatic parenchymal injury prior to hepatic resection for colorectal metastases.
METHODS: Preoperative MRI criteria were used to score 37 patients with colorectal liver metastases by two independent radiologists, blinded to outcomes, for signal drop-out on chemical-shift imaging MRI and ferucarbotran uptake and compared to blinded standardized histopathological endpoints of steatosis, steatohepatitis and sinusoidal dilatation. Sensitivity, specificity, predictive values and the area under the receiver operating characteristic curve (AUC) were calculated for the MRI sequences.
RESULTS: On histology, severe steatosis, steatohepatitis and sinusoidal dilation were evident in 6 (16.2%), 4 (10.8%) and 9 (24.3%) patients respectively. Chemical-shift imaging MRI had a positive predictive value (PPV) of 100% for severe steatosis, 80% for steatohepatitis and zero for sinusoidal dilatation, with an AUC of 1.0, 0.99 and 0.36 respectively. Ferucarbotran-enhanced MRI had a 100% PPV for the detection of severe sinusoidal dilatation, with an AUC of 0.61.
CONCLUSIONS: This study demonstrates that liver-specific MRI can accurately predict the severity of pre-existing hepatic injury. Moreover, it may play a key role in planning the timing and extent of chemotherapy and hepatic resection for colorectal metastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246171     DOI: 10.1016/j.ejso.2009.01.015

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.

Authors:  Na-Young Shin; Myeong-Jin Kim; Joon Seok Lim; Mi-Suk Park; Yong-Eun Chung; Jin-Young Choi; Ki Whang Kim; Young-Nyun Park
Journal:  Eur Radiol       Date:  2011-11-23       Impact factor: 5.315

2.  Oxaliplatin-induced hepatic sinusoidal obstruction syndrome in a patient with gastric cancer: A case report.

Authors:  Fang Liu; Xin Cao; Jin Ye; Xiaoli Pan; Xuefeng Kan; Yuhu Song
Journal:  Mol Clin Oncol       Date:  2017-12-18

3.  Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.

Authors:  Brett Knowles; Fenella K S Welsh; Kandiah Chandrakumaran; Tim G John; Myrddin Rees
Journal:  HPB (Oxford)       Date:  2012-02-28       Impact factor: 3.647

4.  Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.

Authors:  Jozef Urdzik; Tomas Bjerner; Alkwin Wanders; Frans Duraj; Ulf Haglund; Agneta Norén
Journal:  HPB (Oxford)       Date:  2012-08-20       Impact factor: 3.647

5.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

6.  99mTc-mebrofenin hepatobiliary scintigraphy and volume metrics before liver preparation: correlations and discrepancies in non-cirrhotic patients.

Authors:  Boris Guiu; Emmanuel Deshayes; Fabrizio Panaro; Florian Sanglier; Caterina Cusumano; Astrid Herrerro; Olivia Sgarbura; Nicolas Molinari; François Quenet; Christophe Cassinotto
Journal:  Ann Transl Med       Date:  2021-05

Review 7.  Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis.

Authors:  Stuart M Robinson; Colin H Wilson; Alastair D Burt; Derek M Manas; Steven A White
Journal:  Ann Surg Oncol       Date:  2012-07-06       Impact factor: 5.344

8.  Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?

Authors:  Sang-Yong Son; Nam-Joon Yi; Geun Hong; Hyeyoung Kim; Min Su Park; Young Rok Choi; Kyung-Suk Suh; Duck-Woo Kim; Seung-Yong Jeong; Kyu-Joo Park; Jae-Gahb Park; Kuhn-Uk Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-12-15

9.  Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.

Authors:  Xuefeng Kan; Jin Ye; Xinxin Rong; Zhiwen Lu; Xin Li; Yong Wang; Ling Yang; Keshu Xu; Yuhu Song; Xiaohua Hou
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

Review 10.  Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.

Authors:  Xiao-Qian Yang; Jin Ye; Xin Li; Qian Li; Yu-Hu Song
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.